Antonio Bertolotto

Neuroscience Institute Cavalieri Ottolenghi (NICO)

Affiliated withNeuroscience Institute Cavalieri Ottolenghi (NICO)Koelliker Hospital

Research Area

Biography

Antonio Bertolotto has not added Biography.
If you are Antonio Bertolotto and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2023

Other Publications

Article	Year
Implications of neutralising antibodies on therapeutic efficacy. Journal of the neurological sciences\| PubMed ID: 19200862	2009
Monocytes and CD4+ T cells contribution to the under-expression of NR4A2 and TNFAIP3 genes in patients with multiple sclerosis. Journal of neuroimmunology\| PubMed ID: 24852325	2014
Effects of isoxazolo-pyridinone 7e, a potent activator of the Nurr1 signaling pathway, on experimental autoimmune encephalomyelitis in mice. PloS one\| PubMed ID: 25265488	2014
CD19 mRNA quantification improves rituximab treatment-to-target approach: a proof of concept study. Journal of neuroimmunology\| PubMed ID: 25293807	2014
Biological monitoring of IFN-β therapy in Multiple Sclerosis. Cytokine & growth factor reviews\| PubMed ID: 25596967	2015
Evaluation of the impact of neutralizing antibodies on IFNβ response. Clinica chimica acta; international journal of clinical chemistry\| PubMed ID: 25769291	2015
The use of the 25 Sprotte needle markedly reduces post-dural puncture headache in routine neurological practice. Cephalalgia : an international journal of headache\| PubMed ID: 25908221	2016
Vitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis. PloS one\| PubMed ID: 26046356	2015
Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis. Journal of neuroinflammation\| PubMed ID: 26169064	2015
Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells. Journal of neuroinflammation\| PubMed ID: 26259673	2015
Nurr1 reduction influences the onset of chronic EAE in mice. Inflammation research : official journal of the European Histamine Research Society ... [et al.]\| PubMed ID: 26337347	2015
PML risk stratification using anti-JCV antibody index and L-selectin. Multiple sclerosis (Houndmills, Basingstoke, England)\| PubMed ID: 26432858	2016
The efficacy of a Mindfulness Based Intervention for depressive symptoms in patients with Multiple Sclerosis and their caregivers: study protocol for a randomized controlled clinical trial. BMC neurology\| PubMed ID: 26757728	2016
A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patients. Journal of neuroimmunology\| PubMed ID: 26943956	2016
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica. Journal of neurology, neurosurgery, and psychiatry\| PubMed ID: 27113605	2016
Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients. Neurotoxicity research\| PubMed ID: 27159982	2016
Erratum to: Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients. Neurotoxicity research\| PubMed ID: 27913963	2017
Aquaporin-4 antibody titration in NMO patients treated with rituximab: A retrospective study. Neurology(R) neuroimmunology & neuroinflammation\| PubMed ID: 28054001	2017
Detection of potassium channel KIR4.1 antibodies in Multiple Sclerosis patients. Journal of immunological methods\| PubMed ID: 28300540	2017
Drug Efficacy Monitoring in Pharmacotherapy of Multiple Sclerosis With Biological Agents. Therapeutic drug monitoring\| PubMed ID: 28328761	2017
A20 in Multiple Sclerosis and Parkinson's Disease: Clue to a Common Dysregulation of Anti-Inflammatory Pathways? Neurotoxicity research\| PubMed ID: 28337659	2017
Rationale for Therapeutic Drug Monitoring of Biopharmaceuticals in Inflammatory Diseases. Therapeutic drug monitoring\| PubMed ID: 28486309	2017
Computerized posturography is more sensitive than clinical Romberg Test in detecting postural control impairment in minimally impaired Multiple Sclerosis patients. Multiple sclerosis and related disorders\| PubMed ID: 28619432	2017
Biological activity of glatiramer acetate on Treg and anti-inflammatory monocytes persists for more than 10years in responder multiple sclerosis patients. Clinical immunology (Orlando, Fla.)\| PubMed ID: 28642148	2017
The Footprints of Poly-Autoimmunity: Evidence for Common Biological Factors Involved in Multiple Sclerosis and Hashimoto's Thyroiditis. Frontiers in immunology\| PubMed ID: 29527211	2018
Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders. Neurology(R) neuroimmunology & neuroinflammation\| PubMed ID: 30258855	2018
NURR1 deficiency is associated to ADHD-like phenotypes in mice. Translational psychiatry\| PubMed ID: 31455763	2019
NURR1 Impairment in Multiple Sclerosis. International journal of molecular sciences\| PubMed ID: 31574937	2019
Acknowledgement to Authors, Referees and Readers 2019. Neurology and therapy\| PubMed ID: 31701468	2019
The transcription factor Nurr1 is upregulated in amyotrophic lateral sclerosis patients and SOD1-G93A mice. Disease models & mechanisms\| PubMed ID: 32188741	2020
TNFAIP3 Deficiency Affects Monocytes, Monocytes-Derived Cells and Microglia in Mice. International journal of molecular sciences\| PubMed ID: 32325694	2020
Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS ... Neurology and therapy\| PubMed ID: 32410147	2020
Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing-Remitting Multiple Sclerosis Patients. Neurology and therapy\| PubMed ID: 32548740	2020
Overexpression of the ubiquitin-editing enzyme A20 in the brain lesions of Multiple Sclerosis patients: moving from systemic to central nervous system inflammation. Brain pathology (Zurich, Switzerland)\| PubMed ID: 33051914	2021
Exposure to fine particulate matter (PM) hampers myelin repair in a mouse model of white matter demyelination. Neurochemistry international\| PubMed ID: 33587955	2021
A First Phenotypic and Functional Characterization of Placental Extracellular Vesicles from Women with Multiple Sclerosis. International journal of molecular sciences\| PubMed ID: 33809077	2021
Serum neurofilament light chain levels in healthy individuals: A proposal of cut-off values for use in multiple sclerosis clinical practice. Multiple sclerosis and related disorders\| PubMed ID: 34182224	2021
Analysis of the Gadolinium retention in the Experimental Autoimmune Encephalomyelitis (EAE) murine model of Multiple Sclerosis. Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)\| PubMed ID: 34364067	2021
Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor. Frontiers in immunology\| PubMed ID: 34925346	2021
The impact of pre-freezing storage time and temperature on gene expression of blood collected in EDTA tubes. Molecular biology reports\| PubMed ID: 35279776	2022
NURR1-deficient mice have age- and sex-specific behavioral phenotypes. Journal of neuroscience research\| PubMed ID: 35593070	2022
The Selective Agonist for Sphingosine-1-Phosphate Receptors Siponimod Increases the Expression Level of Genes in Microglia Cell Line. Current issues in molecular biology\| PubMed ID: 35723306	2022
sNFL applicability as additional monitoring tool in natalizumab extended interval dosing regimen for RRMS patients. Multiple sclerosis and related disorders\| PubMed ID: 36126541	2022
Tailoring Rituximab According to CD27-Positive B-Cell versus CD19-Positive B-Cell Monitoring in Neuromyelitis Optica Spectrum Disorder and MOG-Associated Disease: Results from a Single-Cente... Neurology and therapy\| PubMed ID: 37166677	2023